Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.
Doximity, Inc. (symbol: DOCS) is a leading digital platform designed specifically for U.S. medical professionals. The company connects over a million healthcare professionals, including more than 70% of U.S. physicians and 45% of nurse practitioners and physician assistants, making it the largest HIPAA-secure medical network in the country.
Founded to enhance the productivity and success of medical professionals, Doximity offers a cloud-based platform that provides members with specialized tools for collaboration, secure patient care coordination, virtual patient visits, career management, and staying informed with the latest medical news and research. Available on the web, iPhone, iPad, Apple Watch, and Android devices, Doximity ensures accessibility and convenience for its users.
In recent years, Doximity has achieved significant milestones, including expanding its user base and enhancing its platform capabilities. The company continues to innovate and form strategic partnerships to deliver valuable services to the medical community.
With a commitment to supporting healthcare professionals in a system increasingly run by executives, Doximity ensures that those who take care of us are well-equipped to succeed in their roles. The company's financial condition remains robust, driven by its growing member base and continuous development of its platform.
For the latest updates on Doximity, including recent achievements and ongoing projects, refer to the news section below.
- Latest News: Source: Doximity
- ---
- ---
- ---
- ---
- ---
- ---
Doximity (NYSE: DOCS) reported strong fiscal 2025 Q1 results, with total revenue up 17% year-over-year to $126.7 million. The company saw significant growth in profitability, with net income increasing 46% to $41.4 million and adjusted EBITDA rising 42% to $65.9 million. Doximity's CEO highlighted record engagement, with 590,000 unique providers using their AI, telehealth, messaging, and scheduling tools. The company's non-GAAP net income margin improved to 44.1% from 37.5% year-over-year. For Q2 FY2025, Doximity expects revenue between $126.5-$127.5 million and adjusted EBITDA of $62.5-$63.5 million. The full-year FY2025 guidance projects revenue of $514-$523 million and adjusted EBITDA of $248.5-$257.5 million.
Doximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, has announced that it will release its fiscal 2025 first quarter financial results on August 8, 2024, after the market closes. The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results. Interested parties can access the live audio webcast on Doximity's Investor Relations page at https://investors.doximity.com/ before the call. A replay of the webcast will be available on the website following the call.
Doximity, a leading digital platform for U.S. medical professionals, announced that CEO Jeff Tangney will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for Wednesday, June 5, 2024, at 2:00 p.m. Central Time. This event provides Doximity an opportunity to showcase its growth strategies and business developments to potential investors and stakeholders.
Doximity's 2024 Physician Compensation Report reveals a 5.9% increase in average physician compensation in 2023, following a 2.4% decline the previous year. The report highlights a 23% gender wage gap, with male physicians earning nearly $102,000 more than female physicians. Additionally, 81% of physicians feel overworked, with 59% considering employment changes, including early retirement. The physician shortage continues to impact 88% of respondents, with 86% expressing concern over the healthcare system’s ability to care for an aging population.
Doximity (NYSE: DOCS) announced their Q4 and Fiscal Year 2024 financial results. For the fiscal year, total revenues reached $475.4 million, a 13% increase year-over-year, and net income grew by 31%. Q4 revenues were $118.1 million, showing a 6% increase. Adjusted EBITDA for the fiscal year rose by 25%, and net income margins improved from 26.9% to 31%. The company reported a diluted net income per share for the fiscal year of $0.72, up from $0.53. Doximity also introduced a $500 million stock repurchase program. The company's financial outlook for fiscal year 2025 includes revenues between $506 million and $518 million, and adjusted EBITDA between $238 million and $250 million.
FAQ
What is the current stock price of Doximity (DOCS)?
What is the market cap of Doximity (DOCS)?
What is Doximity, Inc.?
Who are the primary users of Doximity?
What services does Doximity provide?
Is Doximity accessible on multiple devices?
How does Doximity support healthcare professionals?
What recent achievements has Doximity made?
How does Doximity ensure data security?
Can patients use Doximity?
Is Doximity free to use?
Where can I find the latest news about Doximity?
